- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.03. | AI, Discernment, and the Discipline of Access to Healthcare | ||
| 20.03. | Ending the Voicemail Bottleneck: How Voice AI Is Transforming Patient Access | ||
| 19.03. | Inside One VC's Litmus Test for Investable Healthcare AI Startups | ||
| 19.03. | How PreSeed Is Tackling the Sperm Donor Shortage | ||
| 19.03. | Behavior Changes Happen Outside the Exam Room, But Validation of Lifestyle Medicine Programs Cannot | ||
| 19.03. | When Oral Health Joins the Care Team | ||
| 19.03. | 5 Key Companies Hiring Scientific Sales Reps | ||
| 18.03. | Maternal Health Startup Raises $5.7M to Expand Doula Network Nationwide | ||
| 18.03. | Sutter, Allina Health Combine to Form $26B Health System | ||
| 18.03. | J&J Gets FDA Nod for Plaque Psoriasis Pill Positioned to Compete With Injectables | ||
| 18.03. | Top Fertility Supplements for Women in the U.S.: What to Know | ||
| 18.03. | The Evolving Landscape of Privacy and Cybersecurity: Essential Strategies for Legal and Compliance Professionals | ||
| 18.03. | ChatGPT Health Exposes the Hard Truth About AI in Healthcare | ||
| 18.03. | Data in Motion: A Chief's Front-line Insight and the Future of Health Information Exchange [Video] | ||
| 18.03. | Turquoise Health Snags $40M to Simplify Healthcare Contracts & Payments | ||
| 17.03. | Nadia Care Raises $12M to Increase Access to Community-Centered Maternal Care | ||
| 17.03. | 'Lack of Substantial Evidence' Leads to FDA Rejection of Aldeyra Dry Eye Disease Drug | ||
| 17.03. | The "Third Way" for Digital Health Engagement | ||
| 17.03. | A Transformation Doctors Didn't Expect, But Desperately Need | ||
| 17.03. | Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders | ||
| 17.03. | Why The Epic-Health Gorilla Case Just Got Juicier | ||
| 17.03. | Which FDA Division Has the Most Stability As AI Tools Get Adopted Across the Agency? | ||
| 16.03. | Employer Groups Applaud Bill that Aims to Spur Competition in Healthcare | ||
| 16.03. | Structure Therapeutics Oral GLP-1 Obesity Drug Achieves 'Injectable-Like Efficacy' in Phase 2 Test | ||
| 16.03. | The Real Test for AI Diagnostics Isn't Performance - It's Clinical Adoption |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.